Compare NRT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRT | SRTS |
|---|---|---|
| Founded | 1975 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 67.5M |
| IPO Year | N/A | 2016 |
| Metric | NRT | SRTS |
|---|---|---|
| Price | $7.85 | $4.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 72.3K | 71.4K |
| Earning Date | 12-31-2025 | 02-04-2026 |
| Dividend Yield | ★ 10.27% | N/A |
| EPS Growth | ★ 56.96 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $8,734,568.00 | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | $9.13 | ★ N/A |
| Revenue Growth | ★ 49.16 | N/A |
| 52 Week Low | $4.00 | $3.03 |
| 52 Week High | $8.35 | $9.08 |
| Indicator | NRT | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 67.65 | 68.20 |
| Support Level | $7.18 | $3.65 |
| Resistance Level | $8.35 | $4.64 |
| Average True Range (ATR) | 0.34 | 0.22 |
| MACD | 0.15 | 0.08 |
| Stochastic Oscillator | 78.09 | 83.84 |
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.